Aggrenox side effects by duration, gender and age - a phase IV clinical study of FDA data

Summary:

Side effects are reported by people who take Aggrenox. Common side effects include balance disorder among females, and death among males.

The phase IV clinical study is created by eHealthMe based on 7,326 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 07, 2023

7,326 people who take Aggrenox and have side effects are studied.

What is Aggrenox?

Aggrenox has active ingredients of aspirin; dipyridamole. It is used in stroke. Currently, eHealthMe is studying from 7,541 Aggrenox users.

Number of Aggrenox reports submitted per year:

* Approximation only. Some reports may have incomplete information.

Do you take Aggrenox?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

How the study uses the data?

The study is based on aspirin; dipyridamole (the active ingredients of Aggrenox) and Aggrenox (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Aggrenox:

Aggrenox (7,541 reports)

Common Aggrenox side effects:

Hypotension (abnormally low blood pressure): 839 reports
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 831 reports
Constipation: 768 reports
Headache (pain in head): 670 reports
Pain: 611 reports

All Aggrenox side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

Trulicity and Hemiparesis - now
Tamsulosin and Retinal Pigmentation - a second ago
Colistimethate and Flonase Allergy Relief drug interaction - 11 seconds ago
Gliclazide and Penicillamine drug interaction - 17 seconds ago
Perforomist and Venclexta drug interaction - 23 seconds ago
Solu-Medrol and Haemolytic Uraemic Syndrome - 23 seconds ago
Mycostatin and Cogentin drug interaction - 26 seconds ago
Potassium Chloride and Cellulitis - 26 seconds ago
Ortho-Est and Methocarbamol drug interaction - 30 seconds ago
Wellbutrin and Brexpiprazole drug interaction - 33 seconds ago